Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07829419

Evaluation of Two Monthly Silicone Hydrogel Multifocal Toric in Soft Contact Lens Wearers

To compare the performance of two leading soft multifocal Toric contact lenses.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sacco Eye Group, New York, United States

Loading trial locations.

About this study

Prospective, randomized, subject-masked, bilateral crossover dispensing study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A person is eligible for inclusion in the study if they are:

  • Participants at least 40 years of age.
  • Participants requiring lens powers within the range available for the study lenses.
  • Participants with a spherical refractive error at the corneal plane of plano to -6.00.
  • Participants with a minimum reading add of +0.75DS (based on their spectacle refraction at screening). At least 12 participants will be enrolled per add group: low (+0.75 to +1.25D), medium (+1.50 to +1.75D), and high (+2.00 to +2.50).
  • Participants with refractive astigmatism at the corneal plane of 0.75 to 2.00DC.
  • Best spectacle corrected visual acuity greater than or equal to 20/25 (less than or equal to LogMAR 0.1).
  • Habitually using soft contact lenses (multifocal soft contact lenses, sphere or toric lenses for monovision, or sphere or toric lenses for distance vision correction and spectacles for near vision correction) and have worn lenses at least 3 days a week for at least the past six months.
  • Anticipating being able to wear contact lenses for at least 8 hours a day, 5 days a week.
  • Willing and able to follow instructions and maintain the appointment schedule.

Exclusion criteria

  • Anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear.
  • Any active anterior segment ocular disease that would contraindicate contact lens wear.
  • The use of systemic or ocular medications that would contraindicate contact lens wear.
  • History of herpetic keratitis.
  • History of refractive surgery or irregular cornea.
  • Slit lamp findings that are more serious than grade 1 (see ISO 11980 scale).
  • Inactive (i.e. ghost) vessels greater than 1 mm of penetration into the cornea.
  • Participation of the participant in a contact lens or contact lens care product clinical trial within the previous 90 days if involving orthokeratology, 30 days if involving extended wear, rigid gas permeable corneal and scleral lenses, or 15 days if involving daily disposable, daily wear soft lenses.

Treatment and study plan

Lens A ( comfilcon A)

Device

Daily disposable, soft contact lenses worn for one month

Lens B ( lehfilcon A)

Device

Daily disposable, soft contact lenses worn for one month

Primary outcomes

  1. Ease of handling

    Time frame: 1 month

    Ease of handling for lens removal (0-100)

Study contacts

Contact information is provided by the study sponsor or research team.

Liandra Jung

CONTACT

[email protected]

+19253948002

Sponsors and collaborators

Lead sponsor

CooperVision International Limited (CVIL)

Industry

Registry information

Official study title

Clinical Performance Evaluation of Two Monthly Replacement Silicone Hydrogel Multifocal Toric Lens Designs in Habitual Soft Contact Lens Wearers

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 21, 2026
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.